The Society for Immunotherapy of Cancer (SITC) EU Immuno-Oncology Drug Development Summit at the Agora Cancer Research Center will facilitate understanding, open discussion, and exploration of best practices for modern immuno-oncology drug development while fostering international relationships between regulatory agencies, biotech, pharma, and academic investigators.

Join to learn about the next wave of IO therapeutics and ensure that active, innovative, new therapies are rapidly and appropriately moved into clinical testing.

Explore the best practices for modern IO drug development, including study design, regulatory pathways and emerging technologies.